A detailed history of Conning Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Conning Inc. holds 77,086 shares of PFE stock, worth $2.12 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
77,086
Previous 78,909 2.31%
Holding current value
$2.12 Million
Previous $2.21 Million 1.04%
% of portfolio
0.08%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$27.7 - $31.39 $50,497 - $57,223
-1,823 Reduced 2.31%
77,086 $2.23 Million
Q2 2024

Jul 26, 2024

SELL
$25.26 - $29.6 $1.66 Million - $1.95 Million
-65,728 Reduced 45.44%
78,909 $2.21 Million
Q1 2024

Apr 26, 2024

SELL
$25.89 - $29.73 $27.5 Million - $31.6 Million
-1,063,488 Reduced 88.03%
144,637 $4.01 Million
Q4 2023

Jan 29, 2024

BUY
$26.13 - $33.94 $3.73 Million - $4.85 Million
142,872 Added 13.41%
1,208,125 $34.8 Million
Q3 2023

Oct 26, 2023

BUY
$32.09 - $37.51 $2.69 Million - $3.15 Million
83,876 Added 8.55%
1,065,253 $35.3 Million
Q2 2023

Jul 21, 2023

BUY
$36.12 - $41.79 $807,534 - $934,299
22,357 Added 2.33%
981,377 $36 Million
Q1 2023

Apr 27, 2023

BUY
$39.39 - $51.28 $6.22 Million - $8.1 Million
157,925 Added 19.71%
959,020 $39.1 Million
Q4 2022

Feb 07, 2023

SELL
$41.75 - $54.5 $1.55 Million - $2.02 Million
-37,029 Reduced 4.42%
801,095 $41.1 Million
Q3 2022

Oct 28, 2022

SELL
$43.76 - $53.42 $3.73 Million - $4.56 Million
-85,272 Reduced 9.23%
838,124 $36.6 Million
Q2 2022

Jul 20, 2022

SELL
$46.53 - $55.17 $4.71 Million - $5.59 Million
-101,235 Reduced 9.88%
923,396 $48.4 Million
Q1 2022

May 02, 2022

BUY
$45.75 - $56.69 $1.53 Million - $1.89 Million
33,383 Added 3.37%
1,024,631 $53 Million
Q4 2021

Jan 27, 2022

SELL
$41.32 - $61.25 $8.02 Million - $11.9 Million
-194,026 Reduced 16.37%
991,248 $58.5 Million
Q3 2021

Nov 05, 2021

SELL
$39.25 - $50.42 $9.08 Million - $11.7 Million
-231,306 Reduced 16.33%
1,185,274 $50.9 Million
Q2 2021

Jul 29, 2021

SELL
$35.91 - $40.68 $3.94 Million - $4.46 Million
-109,690 Reduced 7.19%
1,416,580 $55.4 Million
Q1 2021

Apr 23, 2021

BUY
$33.49 - $37.77 $7.25 Million - $8.18 Million
216,599 Added 16.54%
1,526,270 $55.3 Million
Q4 2020

Jan 28, 2021

BUY
$33.47 - $42.56 $1.49 Million - $1.9 Million
44,610 Added 3.53%
1,309,671 $48.2 Million
Q3 2020

Oct 21, 2020

BUY
$31.75 - $37.25 $1.95 Million - $2.29 Million
61,543 Added 5.11%
1,265,061 $46.4 Million
Q2 2020

Aug 07, 2020

SELL
$30.12 - $36.54 $4.35 Million - $5.27 Million
-144,350 Reduced 10.71%
1,203,518 $39.4 Million
Q1 2020

Apr 29, 2020

BUY
$27.03 - $38.62 $1.3 Million - $1.85 Million
47,937 Added 3.69%
1,347,868 $44 Million
Q4 2019

Jan 29, 2020

BUY
$32.92 - $37.36 $1.35 Million - $1.53 Million
40,872 Added 3.25%
1,299,931 $50.9 Million
Q3 2019

Oct 30, 2019

BUY
$32.49 - $42.13 $5.08 Million - $6.59 Million
156,384 Added 14.18%
1,259,059 $45.2 Million
Q2 2019

Jul 25, 2019

SELL
$36.98 - $41.52 $1.82 Million - $2.05 Million
-49,264 Reduced 4.28%
1,102,675 $47.8 Million
Q1 2019

Apr 22, 2019

BUY
$37.5 - $41.2 $1.1 Million - $1.21 Million
29,257 Added 2.61%
1,151,939 $48.9 Million
Q4 2018

Jan 29, 2019

SELL
$38.47 - $43.86 $5.51 Million - $6.28 Million
-143,183 Reduced 11.31%
1,122,682 $49 Million
Q3 2018

Oct 26, 2018

SELL
$34.47 - $41.81 $3.15 Million - $3.83 Million
-91,492 Reduced 6.74%
1,265,865 $55.8 Million
Q2 2018

Jul 25, 2018

BUY
$32.98 - $35.16 $1.67 Million - $1.78 Million
50,498 Added 3.86%
1,357,357 $49.2 Million
Q1 2018

May 04, 2018

BUY
$31.91 - $37.02 $3.67 Million - $4.25 Million
114,903 Added 9.64%
1,306,859 $46.4 Million
Q4 2017

Jan 30, 2018

SELL
$33.26 - $35.29 $387,146 - $410,775
-11,640 Reduced 0.97%
1,191,956 $43.2 Million
Q3 2017

Oct 20, 2017

BUY
$31.0 - $34.15 $37.3 Million - $41.1 Million
1,203,596
1,203,596 $43 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Conning Inc. Portfolio

Follow Conning Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Conning Inc., based on Form 13F filings with the SEC.

News

Stay updated on Conning Inc. with notifications on news.